New drug policy angers multinationals

Published: 2007-12-04 06:59:00

Updated: 2007-12-04 06:59:00

Multinational drug manufacturers complained that their newly-invented and original drugs, which have already been undervalued in Korea, have been dealt a serious blow by the Korean government's plan to allow only cost-effective drugs to be covered by national health insurance.

They argued that...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK